Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $199 | $205 | $216 | $263 |
| - Cash | $4 | $8 | $9 | $4 |
| + Debt | $33 | $36 | $36 | $36 |
| Enterprise Value | $227 | $233 | $243 | $295 |
| Revenue | $43 | $43 | $45 | $39 |
| % Growth | 0.1% | -4.6% | 14.5% | – |
| Gross Profit | $18 | $17 | $19 | $20 |
| % Margin | 41.3% | 40.1% | 42.3% | 50.1% |
| EBITDA | $12 | $11 | $12 | $12 |
| % Margin | 27.5% | 26.1% | 26.6% | 30.5% |
| Net Income | $6 | $6 | $7 | $8 |
| % Margin | 14.8% | 14% | 15.5% | 19.7% |
| EPS Diluted | 16.53 | 15.45 | 17.64 | 19.46 |
| % Growth | 7% | -12.4% | -9.4% | – |
| Operating Cash Flow | $9 | $8 | $9 | $10 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$3 |
| Free Cash Flow | $7 | $7 | $7 | $7 |